Coastal Bridge Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.94M | Sell |
104,583
-1,855
| -2% | -$49.4K | 0.21% | 109 |
|
|
2025
Q4 | $2.65M | Sell |
106,438
-29,808
| -22% | -$752K | 0.2% | 122 |
|
|
2025
Q3 | $3.47M | Sell |
136,246
-41,004
| -23% | -$1.01M | 0.26% | 100 |
|
|
2025
Q2 | $4.3M | Buy |
+177,250
| New | +$4.13M | 0.35% | 76 |
|
|
2025
Q1 | – | Sell |
-37,862
| Closed | -$1M | – | 361 |
|
|
2024
Q4 | $1M | Sell |
37,862
-2,507
| -6% | -$68K | 0.25% | 65 |
|
|
2024
Q3 | $1.17M | Buy |
40,369
+168
| +0.4% | +$4.9K | 0.29% | 59 |
|
|
2024
Q2 | $1.12M | Hold |
40,201
| – | – | 0.28% | 58 |
|
|
2024
Q1 | $1.12M | Buy |
40,201
+6,453
| +19% | +$179K | 0.26% | 64 |
|
|
2023
Q4 | $972K | Buy |
33,748
+809
| +2% | +$24.5K | 0.25% | 66 |
|
|
2023
Q3 | $1.09M | Buy |
32,939
+742
| +2% | +$26.2K | 0.29% | 57 |
|
|
2023
Q2 | $1.18M | Sell |
32,197
-2,896
| -8% | -$113K | 0.29% | 54 |
|
|
2023
Q1 | $1.43M | Sell |
35,093
-468
| -1% | -$20.2K | 0.36% | 47 |
|
|
2022
Q4 | $1.82M | Sell |
35,561
-1,684
| -5% | -$80.7K | 0.52% | 37 |
|
|
2022
Q3 | $1.63M | Buy |
37,245
+2,298
| +7% | +$112K | 0.44% | 42 |
|
|
2022
Q2 | $1.83M | Buy |
34,947
+734
| +2% | +$37.4K | 0.56% | 37 |
|
|
2022
Q1 | $1.77M | Sell |
34,213
-29,844
| -47% | -$1.55M | 0.41% | 43 |
|
|
2021
Q4 | $3.12M | Buy |
64,057
+33,345
| +109% | +$1.65M | 0.65% | 35 |
|
|
2021
Q3 | $1.32M | Buy |
30,712
+117
| +0.4% | +$5.18K | 0.31% | 49 |
|
|
2021
Q2 | $1.2M | Sell |
30,595
-349
| -1% | -$13.6K | 0.25% | 54 |
|
|
2021
Q1 | $1.12M | Buy |
30,944
+976
| +3% | +$34.7K | 0.21% | 50 |
|
|
2020
Q4 | $1.1M | Sell |
29,968
-6,448
| -18% | -$237K | 0.22% | 47 |
|
|
2020
Q3 | $1.27M | Buy |
36,416
+1,197
| +3% | +$42K | 0.39% | 39 |
|
|
2020
Q2 | $1.09M | Buy |
35,219
+322
| +0.9% | +$10.9K | 0.35% | 44 |
|
|
2020
Q1 | $1.08M | Buy |
34,897
+150
| +0.4% | +$5.11K | 0.4% | 40 |
|
|
2019
Q4 | $1.29M | Sell |
34,747
-17
| -0% | -$606 | 0.34% | 39 |
|
|
2019
Q3 | $1.19M | Buy |
34,764
+283
| +0.8% | +$10.3K | 0.4% | 41 |
|
|
2019
Q2 | $1.42M | Buy |
34,481
+160
| +0.5% | +$6.35K | 0.42% | 32 |
|
|
2019
Q1 | $1.38M | Buy |
34,321
+112
| +0.3% | +$4.49K | 0.48% | 32 |
|
|
2018
Q4 | $1.42M | Buy |
34,209
+102
| +0.3% | +$4.23K | 0.56% | 30 |
|
|
2018
Q3 | $1.43M | Buy |
34,107
+3,115
| +10% | +$120K | 0.54% | 26 |
|
|
2018
Q2 | $1.07M | Buy |
30,992
+304
| +1% | +$10.4K | 0.43% | 35 |
|
|
2018
Q1 | $1.03M | Buy |
30,688
+2,547
| +9% | +$87.6K | 0.38% | 37 |
|
|
2017
Q4 | $973K | Sell |
28,141
-2,441
| -8% | -$83.2K | 0.31% | 41 |
|
|
2017
Q3 | $1.04M | Buy |
30,582
+121
| +0.4% | +$3.89K | 0.34% | 37 |
|
|
2017
Q2 | $971K | Buy |
30,461
+609
| +2% | +$19.2K | 0.33% | 33 |
|
|
2017
Q1 | $969K | Buy |
29,852
+117
| +0.4% | +$3.69K | 0.33% | 33 |
|
|
2016
Q4 | $916K | Buy |
29,735
+117
| +0.4% | +$3.57K | 0.36% | 30 |
|
|
2016
Q3 | $952K | Buy |
29,618
+105
| +0.4% | +$3.51K | 0.46% | 18 |
|
|
2016
Q2 | $986K | Buy |
29,513
+105
| +0.4% | +$3.35K | 0.52% | 17 |
|
|
2016
Q1 | $827K | Sell |
29,408
-278
| -0.9% | -$7.94K | 0.58% | 22 |
|
|
2015
Q4 | $909K | Buy |
+29,686
| New | +$934K | 0.51% | 18 |
|
Other funds holding PFE
VCM
VPM
Coastal Bridge Advisors's PFE Position: Q1 2026 in Review
Coastal Bridge Advisors reduced its Pfizer (PFE) stake by 1.7% in Q1 2026, selling an estimated $49.4K and leaving 104,583 shares worth $2.94M. The position accounts for 0.21% of the portfolio, ranked #109.
Coastal Bridge Advisors first reported a position in PFE in Q4 2015 and has held it in 41 quarters since. The position peaked at $4.3M in Q2 2025. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Coastal Bridge Advisors held 104,583 shares of Pfizer worth $2.94M as of Q1 2026.
- Coastal Bridge Advisors sold 1,855 Pfizer shares in Q1 2026, an estimated $49.4K.
- Pfizer made up 0.21% of Coastal Bridge Advisors's portfolio in Q1 2026, its #109 holding.
- Coastal Bridge Advisors first reported a position in Pfizer in Q4 2015 and has held it in 41 quarters since.
- Coastal Bridge Advisors's Pfizer position peaked at $4.3M in Q2 2025.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Coastal Bridge Advisors's 13F filing for Q1 2026, filed 14 May 2026.